0001209191-18-005204.txt : 20180124
0001209191-18-005204.hdr.sgml : 20180124
20180124173322
ACCESSION NUMBER: 0001209191-18-005204
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180122
FILED AS OF DATE: 20180124
DATE AS OF CHANGE: 20180124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Silva Paul M
CENTRAL INDEX KEY: 0001446372
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 18546151
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-22
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001446372
Silva Paul M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
SVP & Corp Controller
Common Stock
2018-01-22
4
M
0
2427
86.52
A
19061
D
Common Stock
2018-01-22
4
S
0
2427
161.52
D
16634
D
Common Stock
2018-01-23
4
M
0
1289
91.05
A
17923
D
Common Stock
2018-01-23
4
M
0
1719
90.29
A
19642
D
Common Stock
2018-01-23
4
S
0
3008
166.05
D
16634
D
Common Stock
169
I
401(k)
Stock Option (Right to Buy)
86.52
2018-01-22
4
M
0
2427
0.00
D
2027-02-02
Common Stock
2427
10517
D
Stock Option (Right to Buy)
91.05
2018-01-23
4
M
0
1289
0.00
D
2026-02-01
Common Stock
1289
11602
D
Stock Option (Right to Buy)
90.29
2018-01-23
4
M
0
1719
0.00
D
2026-07-11
Common Stock
1719
8594
D
Transaction made pursuant to Mr. Silva's company-approved trading plan under Rule 10b5-1.
The option vests in 16 quarterly installments from 2/3/2017.
The option vests in 16 quarterly installments from 2/2/2016.
The option vests in 16 quarterly installments from 7/12/2016.
/s/ Omar White, Attorney-in-Fact
2018-01-24